| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | -0.024 | 0.9 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | 0.0099 | 0.9 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.0098 | 0.9 |
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.0046 | 0.9 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | -0.018 | 0.9 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | 0.0043 | 0.9 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | -0.0046 | 0.9 |